LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 55.40
-0.70 (-1.25%)
Oct 20, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 4.47 billion as of October 20, 2026. It is the 23,118th most valuable company in the world and the 1,172nd biggest in Taiwan. Its market cap has increased by 129.88% in one year.
Market Cap
4.47B
Enterprise Value
3.76B
Revenue
414.67M
Global Rank
Country Rank
#1,172 Taiwan
PE Ratio
11.58
ChartMarket Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 4.47B, an increase of 159.28%. That is a compound annual growth rate of 4.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 4.47B | 70.72% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.26B |
| Orient Pharma | 5.87B |
| Alar Pharmaceuticals | 5.74B |
| Formosa Laboratories | 5.56B |
| Yoda Pharmaceuticals | 5.06B |
| Panion & Bf Biotech | 4.56B |
| Orient EuroPharma | 3.97B |
| Easywell Biomedicals | 3.50B |